• Exchange: Indonesia
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kalbe Farma Tbk PT

+ Add to Watchlist

KLBF:IJ

1,800 IDR 25 1.41%

As of 04:14:23 ET on 12/19/2014.

Snapshot for Kalbe Farma Tbk PT (KLBF)

Open: 1,785 Day's Range: 1,760 - 1,800 Volume: 42,321,500
Previous Close: 1,775 52wk Range: 1,180 - 1,835 1-Yr Rtn: +51.59%

Stock Chart for KLBF

No chart data available.
  • KLBF:IJ 1,800
  • 1D
  • 1M
  • 1Y
1,775
Interactive KLBF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KLBF

Current P/E Ratio (ttm) 40.8590
Estimated P/E(12/2014) 39.7711
Relative P/E vs. JCI 2.0451
Earnings Per Share (IDR) (ttm) 44.0540
Est. EPS (IDR) (12/2014) 45.2590
Est. PEG Ratio 3.2190
Market Cap (M IDR) 84,375,219.80
Shares Outstanding (M) 46,875.12
30 Day Average Volume 35,745,830
Price/Book (mrq) 9.5856
Price/Sale (ttm) 4.8713
Dividend Indicated Gross Yield 0.94%
Cash Dividend (IDR) 17.0000
Dividend Ex-Date 06/16/2014
5 Year Dividend Growth 46.72%
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KLBF

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for KLBF

PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.

Johannes SetijonoPresident CommissionerBernadette Ruth Irawaty SetiadyPresident Director
Budi Dharma WreksoatmodjoVice President DirectorVidjongtius VidjongtiusCFO/Director/Secretary
More Company Profile & Key Executives for KLBF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil